PACAP inhibition as a new mode of action for migraine

被引：0
|
作者：
Klein, Friederike
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2025年 / 150卷 / 06期
关键词：
D O I：
10.1055/a-2464-9044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
If other measures and medications for migraine prophylaxis are not sufficient, inhibitors of CGRP (calcitonin gene-related peptide) are currently an important option. However, many sufferers do not respond adequately to these medications either. Inhibiting the signaling molecule pituitary adenylate cyclase-activating polypeptide (PACAP) could be a new approach to migraine prophylaxis.
引用
收藏
页码：247 / 248
页数：2
相关论文
共 50 条
12345